Medical Services International Moves Into Additional Countries in Africa
January 29 2007 - 2:23PM
PR Newswire (US)
EDMONTON, Alberta, Jan. 29 /PRNewswire-FirstCall/ -- Medical
Services International Inc (OTC:MSITF) wishes to announce that it
has been approached by distributors in an additional 5 countries in
Africa to start supplying the VScan HIV and TB rapid test kits.
Currently it has been reported that the test kits being supplied to
these countries are very inaccurate (less than 80% accuracy when
compared to conventional tests). Inaccurate kits are worse than no
kits as these kits miss HIV positive people, giving a false sense
of security, therefore increasing the spread of HIV. The
distributors have heard about the continued accuracy of the VScan
HIV test kits and have been given copies of the test data from
regulatory bodies in other countries showing the accuracy of the
VScan HIV test kits. The distributors have indicated that this
could result in the purchase of up to an additional 2,000,000 VScan
test kits per year. The Company believes that by the end of 2007,
it will be the largest supplier of HIV, TB, Dengue Fever and
Malaria rapid test kits in the world. About VScan The VScan rapid
test kit is a single use, disposable, accurate, cost effective,
easy to use test for the screening of HIV 1&2, Hepatitis
B&C, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis,
Malaria and Prostate cancer. The kits cannot be sold in Canada.
Medical Services International Inc trades in the United States on
the NQB Pinksheets under the symbol "MSITF". For further
information, please contact Robert Talbot at (780) 430 6363 or
http://www.medicalservicesintl.com/ or
http://www.minerva-biotech.com/ . NOTE: Certain statements in this
press release are "forward-looking statements" within the meaning
of the Private Securities Act of 1995. Such statements involve
known and unknown risks, uncertainties and other factors that may
cause results to differ materially. Such risks, uncertainties and
other factors include but are not limited to new economic
conditions, risk in product development, market acceptance of new
products and continuing product demand, level of competition and
other factors described in Company reports an other filings with
regulatory bodies. DATASOURCE: Medical Services International Inc
CONTACT: Robert Talbot of Medical Services International Inc,
+1-780-430-6363 Web site: http://www.medicalservicesintl.com/
http://www.minerva-biotech.com/
Copyright